CD4 and cutaneous melanoma: In aforementioned study using primary cutaneous melanomas (Stage II), the authors demonstrated that while the presence of GZMB+ TIL was associated with longer OS and progression-free survival (PFS), the presence of CD4+ and CD8+ TIL was associated only with improved PFS and not OS (68).